Rapid Determination of Teicoplanin in Human Plasma by High Performance Liquid Chromatography

Abstract

A rapid isocratic reversed-phase HPLC method for the determination of the major component of teicoplanin in plasma is described.

By using solid phase extraction C18 and UV detection at 240 nm, this method is specific, and sufficiently sensitive.

We found a good linearity over the range: 5 – 40 mg/1 of teicoplanin plasma concentrations. The coefficients of variation did not exceed 5.4% both within-day and between-day assays.

With the small plasma sample required for the analysis (250 μl) and the good accuracy, this rapid procedure appears to be suitable for the therapeutic drug monitoring.     

Determination of Chlordiazepoxide and Its Metabolites in Plasma by High Pressure Liquid Chromatography

Abstract

A rapid, sensitive and specific high pressure liquid chromatographic (HPLC) assay was developed for the determination of chlordiazepoxide and its metabolites from plasma. The assay involves extraction of chlordiazepoxide and its metabolites into diethyl ether from plasma buffered to pH 9. The overall recovery of chlordiazepoxide is 80 ± 5.0% (S.D.) and the sensitivity limit of detection is 50 to 100 ng/ml of plasma, using a 1 ml specimen. The assay was used in the determination of plasma levels of chlordiazepoxide and its metabolites in man following oral administration of chlordiazepoxide. HCl.

The chromatographic behavior of other clinically important benzodiazepines and their major metabolites is also reported.     

Determination of Ibafloxacin,A New Quinolone Antibacterial,in Human and Dog Plasma and Urine by High Performance Liquid Chromatography

Abstract

A simple, selective and sensitive high performance liquid chromatographic method has been developed for quantifying plasma and urine ibafloxacin levels in humans and dogs.

Sample pretreatment is done by incorporation of an internal standard (IS) followed by a single step chloroform extraction. Samples are then chromatographed by reverse phase chromatography with UV detection. The lowest quantifiable concentration is 0.1 μg ibafloxacin/mL with a 1 mL sample. The assay was linear over the range of 0.1–50 μg/mL.     

Determination of Promethazine in Biological Fluids

Abstract

A procedure for the determination of promethazine in plasma and urine has been developed which involves solvent extraction and gas chromatography using an alkaline flame ionisation detector. This procedure is sensitive and reproducible and can be applied to samples from humans receiving therapeutic doses of promethazine.     

Determination of Flecainide in Human Plasma by High Performance Liquid Chromatography with Fluorescence Detection

Abstract

A simple, rapid, selective, and sensitive high-performance liquid chromatographic (HPLC) method for the monitoring of plasma flecainide levels in a therapeutic or research environment is described. The drug is first separated from plasma by a single-step extraction with hexane and then quantitated by HPLC with fluorescence detection. Two linear ranges have been established; 100–2000 ng/ml for drug monitoring in clinical management of patients and 3–300 ng/ml for pharmacokinetic studies. The intra-day variation is less than 6%.     

Comparison of Two Sample Preparation Methods for a HPLC-DAD Assay of Tolbutamide from Human Plasma

ABSTRACT

Two sample preparation methods were applied for the determination of Tolbutamide in the human plasma, at concentration levels ranging from 5 to 50 ppm. One method is based on the drug extraction into ethyl acetate. This solvent has never been used for Tolbutamide extraction from plasma matrix. The other method is a non-extraction one, based on the protein precipitation in presence of methanol. Both methods were successfully applied to in-vivo monitoring of plasma levels of Tolbutamide for a 24-hours period, as required for a pharmacokinetic study. The main parameters in both methods were optimized in order to achieve the acceptance criteria imposed by the bioavailability studies.     

Sensitive HPLC Assay for Ketoprofen in Human Plasma and its Application to Pharmacokinetic Study

Abstract

A selective and sensitive HPLC method was developed for the analysis of ketoprofen in human plasma. The assay involves an extraction of the drug and the internal standard (piroxicam) into diethyl ether from acidified plasma and then back-extracted into a small volume of alkaline aqueous solution before injection onto the HPLC column. A microbore column (2 mm I.D. × 10 cm) packed with a C18 reversed-phase material (5 pm ODS Hypersil) was used. The chromatographic separation was accomplished with a mobile phase comprising a mixture of acetonitrile-methanol-water (15 :20 : 65, v/v) containing 10 mM Na2HP04 buffer, pH 4. The mobile phase was pumped at a flow rate of 0.5 dmin. The eluant was monitored at 258 nm. With this procedure coefficients of variation were less than 10%. The detectionlimit was 0.05 μg/ml (i.e., 50 ng/ml) of plasma. The highly sensitive nature of this method was applied successfully to the dewmination of ketoprofen in human plasma for phmacokinetic studies.     

The “On Line” Determination of Cefsulodin by High Performance Liquid Chromatography in CSF and Plasma of Rats

Abstract

After an intraveinous injection of 20 mg.kg^?1 of cefsulodin in anaesthetized rats, the cerebrospinal fluid (CSF) and plasma drug levels were determined on line by HPLC. The CSF was withdrawn from the IIIe venticle at a flow rate of I μl. minute and pushed with a peristaltic pump, via a teflon tube into a “micro vial” inside the WISP vial. At the end of fiveteen minutes, about 15 μ1 of CSF was collected and a small volume (7 μl) was injected by the WISP into the column, the excess of CSF was discarded by another teflon tube inside the “micro-vial”. After the injection, the continous flow of CSF filled the “micro vial”, an injection was running at fiveteen minutes and so on during three hours. Plasma samples were collected every thirty minutes, and after methanol extraction cefsulodin levels were determined by HPLC. Given the low drug levels found in the CSF, this method appeared very sensitive; it was a direct, rapid, automatic technique. Other biological molecules can be determined by this automatic dosage.     

A New Sensitive Reversed‐phase High‐performance Liquid Chromatography Method for the Quantitative Determination of Metoclopramide in Canine Plasma

Abstract

A specific and sensitive high‐performance liquid chromatographic method was developed for the determination of metoclopramide in canine plasma. The procedure involves fast liquid–liquid extraction and analysis on an octadecyl silane (ODS) column. A preliminary pharmacokinetic study was performed by applying the developed method to a single oral administration of metoclopramide (MCP) to a dog. The validation method yielded good results regarding linearity, precision, accuracy, and specificity. The procedure is suitable for separation and quantification of MCP in canine plasma, enough to quantify 0.2 ng/ml when 0.5 ml of plasma is used. This assay procedure might be useful for the pharmacokinetic study of MCP in dogs.     

Glc Determination of Valproic Acid in Plasma

Abstract

A one-step glc procedure was developed for the quantitative determination of valproic acid in plasma. After addition of internal standard (4-methyl valeric acid), plasma is buffered at pH 4.5 to avoid hydrolysis of valproic acid conjugate (s). Evaporation is avoided by extraction into a chloroform bead. The method is sufficiently sensitive to quantitate 0.8 μg of the drug in 0.2 ml of plasma. The procedure has been thoroughly tested for precision and reproducibility through the determination of over two thousand samples.     

Improved High Pressure Liquid Chromatographic Method for Phenylpropanolamine in Human Plasma

Abstract

A high-pressure liquid chromatographic analysis of phenylpropanolamine in plasma following extraction, back extraction and pre-column derivitization with O-phthalaldehyde is presented. The method is improved by the use of phenylethanolamine as internal standard. Using fluorescence detection, the method is sufficiently sensitive to quantitate 5 ng/ml in 0.5 ml plasma with a standard error of estimate of 2.7 ng/ml when calibrated over the O to 240 ng/ml range. Analysis of over 2000 clinical samples have shown the method to be highly specific and reliable.     

Determination of Pyridostigmine in Human Plasma by High-Performance Liquid Chromatography

Abstract

An easy to perform, specific, reproducible and sensitive high performance liquid chromatographic (HPLC) method to measure pyridostigmine concentration in human plasma was developed and validated. Sample clean-up consists of ion-pair extraction into dichloromethane in the presence of neostigmine as internal standard, followed by back extraction into an aqueous phase. Mean recovery of 110% (with a standard deviation of 10%) was determined for concentrations of 5 – 100 ng/ml. Chromatography on a 125·4 mm CN-propyl column using a mobile phase composed of 10% acetonitrile in 3.5×10^?4M NaH₂PO₄ and UV detection at 270 nm, yields clean chromatograms without any interferences from endogenous plasma components. Using 1 ml plasma samples the method has a limit of detection (LD) of 3 ng/ml, with %CV (precision) and bias (accuracy) ≥ 10% for concentrations in the range of 0–100 ng/ml. The method is being used in human pharmacokinetic studies of oral dosage forms of pyridostigmine.     

Peroxyoxalate chemiluminescence detection for the highly sensitive determination of fluorescence-labeled chlorpheniramine with Suzuki coupling reaction

A sensitive and selective high performance liquid chromatography-peroxyoxalate chemiluminescence (PO-CL) method has been developed for the simultaneous determination of chlorpheniramine (CPA) and monodesmethyl chlorpheniramine (MDCPA) in human serum. The method combines fluorescent labeling with 4-(4,5-diphenyl-1H-imidazole-2-yl)phenyl boronic acid using Suzuki coupling reaction with PO-CL detection. CPA and MDCPA were extracted from human serum by liquid–liquid extraction with n-hexane. Excess labeling reagent, which interfered with trace level determination of analytes, was removed by solid-phase extraction using a C18 cartridge. Separation of derivatives of both analytes was achieved isocratically on a silica column with a mixture of acetonitrile and 60 mM imidazole-HNO₃ buffer (pH 7.2; 85:15, v/v) containing 0.015% triethylamine. The proposed method exhibited a good linearity with a correlation coefficient of 0.999 for CPA and MDCPA within the concentration range of 0.5–100 ng/mL. The limits of detection (S/N = 3) were 0.14 and 0.16 ng/mL for CPA and MDCPA, respectively. Using the proposed method, CPA could be selectively determined in human serum after oral administration.     

Ion-Pair Liquid Chromatographic Analysis of Phenylpropanolamine in Plasma and Urine by Post-Column Derivatization with O-Phthalaldehyde

Abstract

A high pressure Liquid chromatographic analysis of phenylpropano Lamine in plasma and urine by post-column derivatzaition with o-phthalaldehyde is described. Plasma samples are extracted with methylene chloride under alkaline conditions. Urine is diluted with mobile phase without extraction. Using fluorescence detection, the method is sufficiently sensitive (2 ng/ml in 0.5 ml of plasma and 0.5 mcg/ml in 0.2 ml of urine) so that phenylpropano lamine concentrations in plasma or urine may be measured for up to 24 hours following a 75 mg oral dose. Coefficients of variation for inter-day and intra-day precision are less than 10%.     

Automated High-Performance Liquid Chromatographic Technique for Determining Diltiazem and its Three Main Metabolites in Serum

Abstract

A sensitive and automatic method for the analysis of diltiazem and its three main metabolites in acidified serum is described using solid-liquid extraction on disposable extraction cartridges coupled to injection via a loop-column in an HPLC System. This method avoids the in-vitro degradation of diltiazem and its main metabolite MA (N-monodemethyl diltiazem) into M1 (desacetyl diltiazem) and M2 (desacetyl-N-demethyl diltiazem) and eliminates the numerous manipulations involved in liquid-liquid extraction.     

A High-Performance Liquid Chromatographic Method for the Determination of Doxefazepam in Human Plasma Using a Solid-Phase Extraction Column

Abstract

A procedure for the rapid, quantitative isolation of doxefazepam from plasma with Supelclean LC-18 cartridges is described together with a sensitive HPLC assay for the quantitative determination of the drug. The recovery of doxefazepam was greater than 80 % over an investigated range of 0.1–2.0 μg/ml of plasma. The column extraction of doxefazepam coupled with the versatility of HPLC make this procedure well suited for detailed pharmacokinetic studies and as well as routine plasma analysis of doxefazepam.     

High Performance Liquid Chromatongraphy of ABBOTT-53385 in Dog,Rat, and Human Plasma

Abstract

A simple, sensitive and reproducible high-performance liquid chromatographic (HPLC) method was developed to monitor plasma ABBOTT-53385 (I) levels in dogs, rats and humans. The samples were first supplemented with the internal standard, then extracted on Bond Elut® extraction columns. They were analyzed by reverse-phase HPLC with UV detection at 240 nm. The calibration curve was rectilinear over the range of 0.05–2.0 μg/ml and the interday variance was less than 4%. The limit of detection for this method was about 0.03 μg/ml.     

Comparison of Solid-Phase Extraction and Liquid-Liquid Extraction Methods for Liquid Chromatographic Determination of Diltiazem and its Metabolites in Plasma

Abstract

A rapid solid-phase extraction method for the determination of diltiazem and its metabolites from plasma was compared to a conventional liquid-liquid extraction procedure we have described previously. Analytical recovery for all compounds was greater than 90 % for solid-phase extraction whereas for liquid-liquid extraction, mean recovery ranged from 67 to 82 %. The increase of extraction efficiency was closely related to an improvement of the detection limit for the metabolites. Solid phase extraction procedure was found to be more convenient, rapid and sensitive than liquid-liquid extraction and represents a useful analytical tool for the monitoring of diltiazem and its metabolites in clinical investigations.     

Determination of Doxorubicin,Daunorubicin and some of their Metabolites in Mouse Plasma by High-Performance Reversed-Phase Liquid Chromatography with Amperometric Detection

Abstract

A selective and sensitive reversed-phase liquid chromatographic method with electrochemical detection for the analysis of doxorubicin, daunorubicin and some of their metabolites in plasma is reported. A mobile phase consisting of acetonitrile-phosphate buffer solution-tetrahydrofuran (25–71,5–3,5) flowing at 1 ml/min through a Lichrocart RP 18 column was employed. The influence of various parameters on the separation (solvent composition, pH, tetrahydrofuran content) has been examined. An extraction of anthracyclines from plasma was performed using chloroform-ethanol mixture (4: 1) with high extraction efficiency; reproducible results were attained by working with a 1 M phosphate buffer which ensured a real buffering of the plasma samples. The sensitivity of amperometric detection makes this method suitable for analyzing small amounts of the parent drugs and their metabolites. The precision was better than 4% in the range 0.2 to 5 μg/ml plasma.     

High Performance Liquid Chromatoraphic Determination of R-831, A New Antiallergic Agent,in Dogs and Humans

Abstract

A simple, selective and sensitive HPLC method has been developed to measure R-831 levels in dogs and humans. It is an internal standard technique with a single step extraction and one wash. Samples are chromatographed on a reversed-phase system with ultraviolet detection. The lowest detectable concentration for plasma is 25 ng R-831/ml with a 1 ml sample and the linear range is 25–8000 ng R-831/ml. The lowest detectable concentration for urine is 250 ng R-831/ml with a 0.1 ml sample and the linear range is 250–8000 ng R-831/ml. This method has been used to quantitate levels of R-831 in bioavailability and toxicity studies in dogs, and in pharmacokinetic and efficacy studies in humans.